Esperion Therapeutics (ESPR) Inventory: 2020-2025
Historic Inventory for Esperion Therapeutics (ESPR) over the last 6 years, with Sep 2025 value amounting to $108.5 million.
- Esperion Therapeutics' Inventory rose 35.50% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.5 million, marking a year-over-year increase of 35.50%. This contributed to the annual value of $94.5 million for FY2024, which is 43.99% up from last year.
- As of Q3 2025, Esperion Therapeutics' Inventory stood at $108.5 million, which was down 5.18% from $114.5 million recorded in Q2 2025.
- Over the past 5 years, Esperion Therapeutics' Inventory peaked at $114.5 million during Q2 2025, and registered a low of $20.0 million during Q1 2021.
- Over the past 3 years, Esperion Therapeutics' median Inventory value was $80.1 million (recorded in 2024), while the average stood at $77.9 million.
- In the last 5 years, Esperion Therapeutics' Inventory soared by 988.00% in 2021 and then dropped by 13.03% in 2022.
- Quarterly analysis of 5 years shows Esperion Therapeutics' Inventory stood at $34.4 million in 2021, then climbed by 2.35% to $35.2 million in 2022, then soared by 86.42% to $65.6 million in 2023, then soared by 43.99% to $94.5 million in 2024, then soared by 35.50% to $108.5 million in 2025.
- Its Inventory was $108.5 million in Q3 2025, compared to $114.5 million in Q2 2025 and $99.3 million in Q1 2025.